Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Pudendal nerve block versus sacral erector spinae (ESP) block for pain after hemorrhoidectomy

Official title: A Randomized, Double-Blind Trial Comparing Pudendal Block Versus Sacral ESP for Ambulatory Hemorrhoidectomy

Run by Ente Ospedaliero Cantonale, Bellinzona · NCT07350460 · Data updated 2026-11-12

This will test whether the sacral erector spinae (ESP) block gives equal or better pain relief than the pudendal nerve block for adults having elective hemorrhoid surgery.

More Hemorrhoids trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment64 (estimated)
SponsorEnte Ospedaliero Cantonale, Bellinzona
Academic / other
Locations1 site (Bellinzona)
StatusRecruiting
StartedJanuary 5, 2026
Main results expectedSeptember 29, 2027
Study endsSeptember 30, 2027
Registry record updatedMarch 18, 2026
Trial IDNCT07350460 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older scheduled for elective excisional hemorrhoidectomy who can provide informed consent, are ASA I–III, and meet the study's weight and BMI limits (not under 50 kg and BMI ≤40) are ideal candidates.

Probably not a fit

Patients who are pregnant, weigh under 50 kg, have BMI >40, have allergies to local anesthetics, significant coagulation disorders or anticoagulation, infection at the puncture site, relevant neurological disorders, severe psychiatric illness, or language barriers will be excluded and are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Hemorrhoidectomy commonly causes significant postoperative pain that can slow recovery and increase unplanned healthcare use. The PUSHES trial randomizes 64 adults undergoing elective excisional hemorrhoidectomy under standardized spinal anesthesia to receive either an ultrasound-guided sacral ESP block or a pudendal nerve block, with sham procedures to maintain blinding. Outcomes include postoperative pain scores, opioid consumption, and recovery metrics such as time to discharge. The sacral ESP block is a newer, potentially simpler ultrasound-guided technique that may offer easier performance and a favorable safety profile compared with the pudendal block.

Why it matters

Potential benefit: If successful, the sacral ESP block could provide equal or better pain relief while being easier and safer to perform, potentially speeding recovery and reducing unplanned visits after hemorrhoidectomy.

How similar studies have gone: The pudendal block is an established option for postoperative analgesia, while sacral ESP blocks have encouraging case reports and small series but lack robust randomized trial evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (≥18 years old) scheduled for elective excisional hemorrhoidectomy;
* Ability to understand the nature of the study and provide written informed consent;
* American Society of Anesthesiologists (ASA) physical status I-III;
* Ability to comply with study procedures and postoperative evaluations.

Exclusion Criteria:

* Pregnancy;
* Body weight under 50 kg due to the potential risk of local anaesthetic systemic toxicity (LAST);
* BMI \> 40; Known allergy or contraindication to local anaesthetics (e.g., ropivacaine, prilocaine);
* Severe coagulation disorders or current anticoagulant therapy contraindicating spinal or peripheral deep nerve blocks (like pudendal block, because Sacral ESP is considered a superficial block);
* Infection at the puncture site;
* Neurological disorders affecting the sacral or pudendal nerve pathways;
* Severe psychiatric conditions impairing study participation;
* Language barriers

Where it's running

  • Ospedale Regionale Bellinzona e Valli (ORBV) CH-6500 Bellinzona Switzerland
    Bellinzona, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.